Cargando…
Adalimumab: a Treatment Option for Pyoderma Gangrenosum After Failure of Systemic Standard Therapies
BACKGROUND: Pyoderma gangrenosum (PG) belongs to a group of neutrophilic dermatoses and is often associated with systemic disorders. The authors present a patient with a recalcitrant PG that did not respond to systemic standard therapies, and discuss further treatment options with impact on quality...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare Communications
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3510423/ https://www.ncbi.nlm.nih.gov/pubmed/23205329 http://dx.doi.org/10.1007/s13555-012-0006-6 |